An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19
Clinical trial NCT04436471 · COMPLETED
Trial details
- NCT number
- NCT04436471
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-08-03
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.